AIM
OLMA icon

Axiom Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History

Axiom Investment Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125 Buy
+10
New +$134 ﹤0.01% 506

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Axiom Investment Management's OLMA Position: Q2 2026 in Review

Axiom Investment Management opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 10 shares worth $125. The stake represents ﹤0.01% of the portfolio and ranks #506 among its holdings.

60 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Axiom Investment Management held 10 shares of Olema Pharmaceuticals worth $125 as of Q2 2026.
  • Olema Pharmaceuticals was a new Axiom Investment Management position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Axiom Investment Management's portfolio in Q2 2026, its #506 holding.
  • 60 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.